Results 191 to 200 of about 930,316 (312)

Multi-Marker Testing for Cancer: What can we Learn from Modern Prenatal Testing for Trisomy-21

open access: yesCancer Informatics, 2006
Erasmus Schneider Ph.D.   +1 more
doaj   +1 more source

Enemy release: loss of parasites in invasive freshwater bivalves Sinanodonta woodiana and Corbicula fluminea

open access: yesEcography, EarlyView.
Invasive freshwater bivalves harm native species, ecosystems and biodiversity, and incur economic costs. The enemy release hypothesis posits that invasive species are released from enemies during the invasion process, giving them a competitive advantage in the new environment.
Binglin Deng   +8 more
wiley   +1 more source

Shifting baselines increase the risk of misinterpreting biodiversity trends

open access: yesEcography, EarlyView.
Ecological studies quantifying the impact of land‐use change on biodiversity may be sensitive to the choice of reference points – or baselines – particularly when sampling across human land‐use gradients and other space‐for‐time comparisons. Much depends on whether the chosen baseline has already undergone shifts in species composition because of ...
Ariane Dellavalle   +13 more
wiley   +1 more source

GaIn‐Induced Polarization Control in PVDF for High‐Efficiency Energy Harvesting and Instantaneous Wireless Sensing

open access: yesENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
This study presents a liquid metal–engineered β‐PVDF composite enabling high‐performance piezoelectric–triboelectric nanogenerators. Guided by MD/DFT simulations, GaIn doping promotes β‐phase formation and dipole alignment, while native oxides enhance charge retention.
Jiaqi Lu   +13 more
wiley   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy